Fuse Biotherapeutics Raises An Oversubscribed And Upsized Seed Financing Round Of $9.5 Million
Round Type
Seed
Los AngelesHealthcareDescription
Fuse Biotherapeutics, a company focused on developing next generation immune modulating therapeutics that directs and potentiates both innate and adaptive immunity, today announced it has secured an oversubscribed and upsized $9.5 million Seed round. The round was led by Viva BioInnovator, the specialized investment and incubation arm of Viva Biotech. Also participating were Sherpa Healthcare Partners, Ivy Venture Group, Sirona Capital, and GC&H Investments. Proceeds from this financing will support the development of the Company's proprietary platform, which leverages the inherent capacity of NK cells to distinguish between normal and diseased tissues.
Quick answer
Fuse Biotherapeutics, Inc. raised an undisclosed amount in a Seed round, dated November 15, 2021. Fuse Biotherapeutics, Inc. is based in Los Angeles, California, United States.
- How much did Fuse Biotherapeutics, Inc. raise?
- Fuse Biotherapeutics, Inc. raised an undisclosed amount in a Seed round on November 15, 2021.
- What does Fuse Biotherapeutics, Inc. do?
- Fuse Biotherapeutics, Inc. is a biotechnology company that is dedicated to developing transformative immune modulating therapeutics for patients with cancer.
- Where is Fuse Biotherapeutics, Inc. based and how big is it?
- Fuse Biotherapeutics, Inc. is based in Los Angeles, California, United States.
Source: Fundz verified event record.
Who else raised in Healthcare around the same time
Companies in the same sectors as Fuse Biotherapeutics, Inc. that raised within 45 days of this round, from Fundz verified event records.
- InterRad Medical, Inc. raised $50K (Seed) on December 30, 2021.
- CROSS COUNTRY HEALTHCARE raised $1.5M on December 30, 2021.
- Nia Therapeutics raised $2M (Seed) on December 30, 2021.
- Arbutus raised $15M on December 30, 2021.
- Can-Fite BioPharma Ltd. raised $10M on December 30, 2021.
- Hand In Hand Health, Inc. raised $7.1M on December 30, 2021.
Who to call at Fuse Biotherapeutics, Inc., and when
A new round usually means Fuse Biotherapeutics, Inc. is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Fuse Biotherapeutics, Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Fuse Biotherapeutics, Inc., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Fuse Biotherapeutics, Inc.. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Fuse Biotherapeutics, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Fuse Biotherapeutics, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.